Pre-exposure Prophylaxis Recent Adherence With Real-Time Adherence Feedback and Partner Human Immunodeficiency Virus Self-Testing: A Pilot Trial Among Postpartum Women

Postpartum women who initiated PrEP during pregnancy with the PrEP-PP study were randomized 1:1 to the intervention (HIVST, biofeedback counseling after urine tenofovir test) or to SOC (facility-based HIV test, routine counseling without biofeedback). HIVST for partners and biofeedback counseling increased levels of PrEP adherence.

Resource Details

Study Type
Pilot study, Randomized clinical trial (RCT)
Year
2021
Population
HIV-uninfected women, Pregnant Women
Author
Joseph Davey DL, Dovel K, Mvududu R, Nyemba D, Mashele N, Bekker LG, Gorbach PM, Coates TJ, Myer L.

More Publications & Resources

PrEP including LEN Fact Sheet for PBFP

PrEP including LEN Fact Sheet for PBFP

PrEP including LEN Counselling Guide for PBFP

PrEP including LEN Counselling Guide for PBFP

LEN Learning Clinic 2: Clinical Considerations for the Implementation of LEN

LEN Learning Clinic 2: Clinical Considerations for the Implementation of LEN

Kenya Integrated Guidelines for Prevention, Treatment and Management of HIV, Sexually Transmitted Infections and Viral Hepatitis, 2026

Kenya Integrated Guidelines for Prevention, Treatment and Management of HIV, Sexually Transmitted Infections and Viral Hepatitis, 2026

Providing PrEP to Pregnant and Breastfeeding Women

Providing PrEP to Pregnant and Breastfeeding Women

Clinical Practice Guidelines for Providing PrEP for Pregnant and Breastfeeding Populations

Clinical Practice Guidelines for Providing PrEP for Pregnant and Breastfeeding Populations

Guidelines on Lenacapavir for HIV Prevention and Testing Strategies for Long-Acting Injectable Pre-Exposure Prophylaxis

Guidelines on Lenacapavir for HIV Prevention and Testing Strategies for Long-Acting Injectable Pre-Exposure Prophylaxis

PrEP and PEP Guidelines-Zambia

PrEP and PEP Guidelines-Zambia

PrEP Lenacapavir Implementation Guidelines

PrEP Lenacapavir Implementation Guidelines

Provider Training Toolkit on Use of Oral and Long-acting HIV PrEP: Lenacapavir-Focused Learning Pathway (Lessons 1-4)

Provider Training Toolkit on Use of Oral and Long-acting HIV PrEP: Lenacapavir-Focused Learning Pathway (Lessons 1-4)

Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP

Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP

Inclusion of Pregnant and Lactating People in the PURPOSE 1 Study: Efficacy, Safety, and Pharmacokinetics

Inclusion of Pregnant and Lactating People in the PURPOSE 1 Study: Efficacy, Safety, and Pharmacokinetics

No results found.